These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 15522470

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.
    Lewis EF, Velazquez EJ, Solomon SD, Hellkamp AS, McMurray JJ, Mathias J, Rouleau JL, Maggioni AP, Swedberg K, Kober L, White H, Dalby AJ, Francis GS, Zannad F, Califf RM, Pfeffer MA.
    Eur Heart J; 2008 Mar; 29(6):748-56. PubMed ID: 18308687
    [Abstract] [Full Text] [Related]

  • 3. Long-term prognostic importance of resting heart rate in patients with left ventricular dysfunction in connection with either heart failure or myocardial infarction: the DIAMOND study.
    Fosbøl EL, Seibaek M, Brendorp B, Moller DV, Thune JJ, Gislason GH, Torp-Pedersen C, Køber L, Danish Investigations and Arrhythmia ON Dofetilide Study Group.
    Int J Cardiol; 2010 Apr 30; 140(3):279-86. PubMed ID: 19095316
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.
    Lipinski MJ, Vetrovec GW, Gorelik D, Froelicher VF.
    J Card Fail; 2005 Oct 30; 11(8):624-30. PubMed ID: 16230267
    [Abstract] [Full Text] [Related]

  • 8. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
    Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Hospitals.
    J Am Coll Cardiol; 2007 Aug 21; 50(8):768-77. PubMed ID: 17707182
    [Abstract] [Full Text] [Related]

  • 9. Heart failure after acute coronary syndrome: identify to treat better!
    Rocha S, Nabais S, Magalhães S, Salgado A, Azevedo P, Torres M, Marques J, Pereira MA, Correia A.
    Rev Port Cardiol; 2007 Apr 21; 26(4):349-59. PubMed ID: 17695730
    [Abstract] [Full Text] [Related]

  • 10. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA, VALIANT Investigators.
    Circulation; 2005 Nov 29; 112(22):3391-9. PubMed ID: 16301343
    [Abstract] [Full Text] [Related]

  • 11. Risk of heart failure complication during hospitalization for acute myocardial infarction in a contemporary population: insights from the National Cardiovascular Data ACTION Registry.
    Shah RV, Holmes D, Anderson M, Wang TY, Kontos MC, Wiviott SD, Scirica BM.
    Circ Heart Fail; 2012 Nov 29; 5(6):693-702. PubMed ID: 23051950
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT).
    Shamshad F, Kenchaiah S, Finn PV, Soler-Soler J, McMurray JJ, Velazquez EJ, Maggioni AP, Califf RM, Swedberg K, Kober L, Belenkov Y, Varshavsky S, Pfeffer MA, Solomon SD, VALsartan In Acute myocardial iNfarcTion (VALIANT) Trial Investigators.
    Am Heart J; 2010 Jul 29; 160(1):145-51. PubMed ID: 20598985
    [Abstract] [Full Text] [Related]

  • 14. Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction.
    Cleland JG, Torabi A, Khan NK.
    Heart; 2005 May 29; 91 Suppl 2(Suppl 2):ii7-13; discussion ii31, ii43-8. PubMed ID: 15831613
    [Abstract] [Full Text] [Related]

  • 15. Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction.
    Aguilar D, Skali H, Moyé LA, Lewis EF, Gaziano JM, Rutherford JD, Hartley LH, Randall OS, Geltman EM, Lamas GA, Rouleau JL, Pfeffer MA, Solomon SD.
    J Am Coll Cardiol; 2004 Jun 02; 43(11):2015-21. PubMed ID: 15172406
    [Abstract] [Full Text] [Related]

  • 16. Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance.
    Weir RA, McMurray JJ, Velazquez EJ.
    Am J Cardiol; 2006 May 22; 97(10A):13F-25F. PubMed ID: 16698331
    [Abstract] [Full Text] [Related]

  • 17. Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.
    Thomas KL, Al-Khatib SM, Lokhnygina Y, Solomon SD, Kober L, McMurray JJ, Califf RM, Velazquez EJ.
    Am Heart J; 2008 Jan 22; 155(1):87-93. PubMed ID: 18082495
    [Abstract] [Full Text] [Related]

  • 18. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP, Hranitzky PM, Kilaru R, Rouleau JL, White HD, Aylward PE, Van de Werf F, Solomon SD, Califf RM, Velazquez EJ.
    Am J Cardiol; 2008 Dec 01; 102(11):1427-32. PubMed ID: 19026290
    [Abstract] [Full Text] [Related]

  • 19. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein.
    Suleiman M, Khatib R, Agmon Y, Mahamid R, Boulos M, Kapeliovich M, Levy Y, Beyar R, Markiewicz W, Hammerman H, Aronson D.
    J Am Coll Cardiol; 2006 Mar 07; 47(5):962-8. PubMed ID: 16516078
    [Abstract] [Full Text] [Related]

  • 20. Myocardial infarction and heart failure hospitalization rates in Maine, USA - variability along the urban-rural continuum.
    Harris DE, Aboueissa AM, Hartley D.
    Rural Remote Health; 2008 Mar 07; 8(2):980. PubMed ID: 18627216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.